Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris

European Respiratory Journal

Volumn 50, Issue 2, 2017, Pages

  Duchemann, Boris ^a,b   Annesi Maesano, Isabella ^c   De Naurois, Camille Jacobe ^d   Sanyal, Shreosi ^c   Brillet, Pierre Yves ^a,b   Brauner, Michel ^a   Kambouchner, Marianne ^a   Huynh, Sophie ^e   Naccache, Jean Marc ^f   Borie, Raphael ^g   Piquet, Jacques ^h   Mekinian, Arsène ⁱ   Virally, Jerôme ^e   Uzunhan, Yurdagul ^a,b   Cadranel, Jacques ^f   Crestani, Bruno ^g   Fain, Olivier ⁱ   Lhote, Francois ^j   Dhote, Robin ^a   Saidenberg Kermanac'h, Nathalie ^a   Rosental, Paul André ^k   Valeyre, Dominique ^a,b   Nunes, Hilario ^a,b   more..

^a AVICENNE HOSPITAL   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d Mission Assurance Maladie   (France)

^e Centre Hospitalier Robert Ballanger CHRB   (France)

^f HÔPITAL TENON   (France)

^g BICHAT HOSPITAL   (France)

^h Monfermeil Hospital   (France)

ⁱ HÔPITAL JEAN VERDIER   (France)

^j Saint Denis Hospital   (France)

^k SCIENCES PO   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ADULT; AFRICAN CARIBBEAN; ALLERGIC PNEUMONITIS; ARTICLE; CHRONIC IDIOPATHIC EOSINOPHILIC PNEUMONIA; CONNECTIVE TISSUE DISEASE ASSOCIATED INTERSTITIAL LUNG DISEASE; CONTROLLED STUDY; DESQUAMATIVE INTERSTITIAL PNEUMONIA; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED INTERSTITIAL LUNG DISEASE; ETHNIC DIFFERENCE; EUROPEAN; FEMALE; FIBROSING ALVEOLITIS; FRANCE; HUMAN; IDIOPATHIC NONSPECIFIC INTERSTITIAL PNEUMONIA; INCIDENCE; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS PROTEINOSIS; LUNG SARCOIDOSIS; LYMPHANGIOLEIOMYOMATOSIS; LYMPHOID INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; NORTH AFRICAN; OBSERVATIONAL STUDY; OCCUPATIONAL INTERSTITIAL LUNG DISEASE; ORGANIZING PNEUMONIA; PNEUMOCONIOSIS; PREVALENCE; PRIORITY JOURNAL; PULMONARY LANGERHANS CELL HISTIOCYTOSIS; RESPIRATORY BRONCHIOLITIS WITH INTERSTITIAL LUNG DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; URBAN AREA; ADOLESCENT; AGE DISTRIBUTION; AGED; CONNECTIVE TISSUE DISEASE; ETHNIC GROUP; MIDDLE AGED; SEX RATIO; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CONNECTIVE TISSUE DISEASES; ETHNIC GROUPS; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PARIS; PREVALENCE; SARCOIDOSIS, PULMONARY; SEX DISTRIBUTION; YOUNG ADULT;

EID: 85027884478     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.02419-2016     Document Type: Article

References (36)

1. Coultas DB, Zumwalt RE, Black WC, et al. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150: 967-972.
2. Demedts M, Wells AU, Antó JM, et al. Interstitial lung diseases: an epidemiological overview. Eur Respir J 2001; 18: 2s-16s.
3. Karakatsani A, Papakosta D, Rapti A, et al. Epidemiology of interstitial lung diseases in Greece. Respir Med 2009; 103: 1122-1129.
4. Musellim B, Okumus G, Uzaslan E, et al. Turkish Interstitial Lung Diseases Group. Epidemiology and distribution of interstitial lung diseases in Turkey. Clin Respir J 2014; 8: 55-62.
5. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
6. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society Statement: update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2013; 188: 733-748.
7. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med 2000; 161: 646-664.
8. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
9. Nalysnyk L, Cid-Ruzafa J, Rotella P, et al. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev 2012; 21: 355-361.
10. Harari S, Madotto F, Caminati A, et al. Epidemiology of idiopathic pulmonary fibrosis in Northern Italy. PloS One 2016; 11: e0147072.
11. Hopkins RB, Burke N, Fell C, et al. Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada. Eur Respir J 2016; 48: 187-195.
12. Behr J, Kreuter M, Hoeper MM, et al. Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry. Eur Respir J 2015; 46: 186-196.
13. Hyldgaard C, Hilberg O, Muller A, et al. A cohort study of interstitial lung diseases in central Denmark. Respir Med 2014; 108: 793-799.
14. Valeyre D, Duchemann B, Nunes H, et al. Interstitial lung diseases. In: Annesi-Maesano I, Lundbäck B, Viegi G, eds. Respiratory Epidemiology (ERS Monograph). Sheffield, European Respiratory Society, 2014; pp. 79-87.
15. Insee. Populations légales 2013-93-Seine-Saint-Denis. http://www.insee.fr/fr/ppp/bases-de-donnees/recensement/populations-legales/departement.asp?dep=93&annee=2013.
16. Gordon-Larsen P, McMurray RG, Popkin BM. Adolescent physical activity and inactivity vary by ethnicity: the National Longitudinal Study of Adolescent Health. J Pediatr 1999; 135: 301-306.
17. Radin JM, Hawksworth AW, Kammerer PE, et al. Epidemiology of pathogen-specific respiratory infections among three US populations. PLoS One 2014; 9: e114871.
18. Raghu G, Chen S-Y, Yeh W-S, et al. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. Lancet Respir Med 2014; 2: 566-572.
19. Thomeer M, Demedts M, Vandeurzen K. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg 2001; 56: 163-172.
20. Fischer A, du Bois R. Interstitial lung disease in connective tissue disorders. Lancet 2012; 380: 689-698.
21. Singh S, Collins BF, Sharma BB, et al. Interstitial lung disease (ILD) in India: results of a prospective registry. Am J Respir Crit Care Med 2017; 195: 801-813.
22. Fernández Pérez ER, Daniels CE, Schroeder DR, et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest 2010; 137: 129-137.
23. Hodgson U, Laitinen T, Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 2002; 57: 338-342.
24. Lai C-C, Wang C-Y, Lu H-M, et al. Idiopathic pulmonary fibrosis in Taiwan - a population-based study. Respir Med 2012; 106: 1566-1574.
25. von Plessen C, Bergman B, Andresen O, et al. Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer. Br J Cancer 2006; 95: 966-973.
26. Raghu G, Weycker D, Edelsberg J, et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174: 810-816.
27. Agabiti N, Porretta MA, Bauleo L, et al. others. Idiopathic pulmonary fibrosis (IPF) incidence and prevalence in Italy. Sarcoidosis Vasc Diffuse Lung Dis 2014; 31: 191-197.
28. Gribbin J, Hubbard RB, Le Jeune I, et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006; 61: 980-985.
29. Hutchinson J, Fogarty A, Hubbard R, et al. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J 2015; 46: 795-806.
30. Raghu G, Chen S-Y, Hou Q, et al. Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old. Eur Respir J 2016; 48: 179-186.
31. Rare diseases act of 2002, public law 107-280-NOV. [cited 2016 May 10]. https://history.nih.gov/research/downloads/PL107-280.pdf Date last accessed: May 10, 2016.
32. European Commission Health & Consumer Protection Directorate-Gene. Useful information of rare diseases from an EU perspective. http://ec.europa.eu/health/ph-information/documents/ev20040705-rd05-en.pdf Date last access: May 10, 2016.
33. Baughman RP, Field S, Costabel U, et al. Sarcoidosis in America. analysis based on health care use. Ann Am Thorac Soc 2016; 13: 1244-1252.
34. Arkema EV, Grunewald J, Kullberg S, et al. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir J 2016; 48: 1690-1699.
35. Swigris JJ, Olson AL, Huie TJ, et al. Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death. Respir Med 2012; 106: 588-593.
36. Mahr A, Guillevin L, Poissonnet M, et al. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004; 51: 92-99.